Shanghai Hajime Advanced Material Technology Inkomsten in het verleden
Verleden criteriumcontroles 4/6
Shanghai Hajime Advanced Material Technology has been growing earnings at an average annual rate of 4.2%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 7.2% per year. Shanghai Hajime Advanced Material Technology's return on equity is 12.3%, and it has net margins of 20.1%.
Belangrijke informatie
4.2%
Groei van de winst
-4.0%
Groei van de winst per aandeel
Chemicals Groei van de industrie | 12.1% |
Inkomstengroei | 7.2% |
Rendement op eigen vermogen | 12.3% |
Nettomarge | 20.1% |
Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Shanghai Hajime Advanced Material Technology geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Sep 24 | 688 | 139 | 66 | 31 |
30 Jun 24 | 644 | 131 | 61 | 28 |
31 Mar 24 | 618 | 119 | 62 | 27 |
31 Dec 23 | 591 | 103 | 62 | 26 |
30 Sep 23 | 564 | 87 | 59 | 22 |
30 Jun 23 | 575 | 94 | 60 | 23 |
31 Mar 23 | 527 | 87 | 52 | 23 |
01 Jan 23 | 535 | 94 | 51 | 24 |
30 Sep 22 | 551 | 111 | 48 | 26 |
30 Jun 22 | 526 | 111 | 44 | 25 |
31 Mar 22 | 574 | 115 | 51 | 24 |
01 Jan 22 | 584 | 116 | 51 | 24 |
30 Sep 21 | 599 | 120 | 52 | 23 |
30 Jun 21 | 601 | 118 | 51 | 21 |
31 Mar 21 | 544 | 112 | 44 | 19 |
31 Dec 20 | 495 | 104 | 40 | 17 |
31 Dec 19 | 335 | 72 | 35 | 14 |
31 Dec 18 | 295 | 53 | 37 | 14 |
31 Dec 17 | 233 | 30 | 40 | 10 |
Kwaliteitswinsten: 301000 has a high level of non-cash earnings.
Groeiende winstmarge: 301000's current net profit margins (20.1%) are higher than last year (15.5%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 301000's earnings have grown by 4.2% per year over the past 5 years.
Versnelling van de groei: 301000's earnings growth over the past year (58.8%) exceeds its 5-year average (4.2% per year).
Winst versus industrie: 301000 earnings growth over the past year (58.8%) exceeded the Chemicals industry -3.8%.
Rendement op eigen vermogen
Hoge ROE: 301000's Return on Equity (12.3%) is considered low.